Revenue
$361.8m
+13.1% ↑ vs $319.9m
IFRS earnings dropped on lower investment property fair-value uplifts, masking a 26% jump in unit settlements and 23.7% rise in operating cash flow.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
FY25 vs FY24
Revenue
$361.8m
+13.1% ↑ vs $319.9m
Net profit after tax
$259.7m
-23.6% ↓ vs $339.8m
Net cash inflow from operating activities
$548.2m
+23.7% ↑ vs $443.2m
Full-year dividend per share
24.5c
flat vs 24.5c
Profit before tax
$241.1m
-32.2% ↓ vs $355.8m
Cash and cash equivalents
$6m
-48.3% ↓ vs $11.7m
Total assets
$9.2b
+14.5% ↑ vs $8.1b
What changed
Profit before tax fell 32.2% to $241.1m and net profit after tax fell 23.6% to $259.7m, even though revenue grew 13.1% to $361.8m and the company's underlying profit measure rose 13% to $234.2m. The gap sits in the investment property fair-value line that flows through IFRS profit at this issuer.
Operationally, 1,560 ORA Operating cash flow settlements were completed, up 26% on FY24's 1,238, and operating cash flow climbed 23.7% to $548.2m. Capex of $647.1m exceeded the prior year's $611.4m, so free cash flow before leases remained negative at -$98.9m. Gross borrowings rose 15% to $2b and cash on hand fell to $6.0m, taking net debt to roughly $2b.
What matters
Revenue grew 13.1%, unit settlements jumped 26%, and operating cash flow rose 23.7%, so the 32.2% PBT decline reflects a smaller fair-value uplift on investment property versus the prior year. The implication: investors reading the IFRS NPAT line in isolation will overstate any deterioration in the underlying retirement village business.
Tax distortion narrows the apparent NPAT decline. The effective tax rate moved from -4.5% in FY24 (a net tax benefit) to 7.7% in FY25, which is why NPAT fell only 23.6% while PBT fell 32.2%, an 8.6 percentage-point gap. PBT is the cleaner read on the year-over-year direction.
Leverage and capital intensity continue to rise. Capex consumed 178.9% of revenue, gross borrowings grew $257.0m, and ROE fell to 7.8% from 11.4%. The business is funding development through additional debt and DMF/resident loan inflows; cash earnings cover neither the development pipeline nor the dividend without continued borrowing.
Expectations
H1 FY25 contributed 47.8% of full-year revenue and 49% of NPAT, which is consistent with the company's slightly second-half-weighted shape and indicates that the H2 cadence broadly followed H1's improved sales momentum.
Management commentary in the half-year release flagged improving sales contract rates and growing stock under contract. The full-year volume outcome (1,560 ORA sales vs. 1,238) is consistent with that signal having carried through H2. What the release does not support is any read on the durability of revaluation gains, which drive a large share of reported IFRS profit and which compressed materially in FY25.
Quality of result
Settlement volumes, revenue, and operating cash flow all grew in double digits, and the strong OCF (+23.7%) outpaced revenue growth (+13.1%), so cash generation kept up with reported activity. NTA per share rose to $13.75 from $12.53, a 9.7% increase, reinforcing that book value continued to compound through the year.
Three quality caveats temper the read. First, NPAT was flattered by the effective tax rate moving from -4.5% to 7.7% — the prior comparable benefited from a tax credit, so the headline NPAT change understates the underlying PBT swing. Second, fair-value movements on investment property remain a large and volatile component of IFRS earnings, and FY25's PBT decline largely reflects that volatility rather than operating weakness. Third, free cash flow before leases remained negative at -$98.9m and capex absorbed 178.9% of revenue, so dividend capacity continues to depend on debt drawdowns and DMF inflows rather than on cash earnings from operations.
Unresolved
This briefing cannot assess the components of the investment property fair-value movement, the cost-to-build trajectory by village cohort, or forward unit pricing in either New Zealand or Australia from the disclosures supplied.
Chat
Ask follow-up questions about Summerset Group Holdings's FY25 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Annual Report FY25
FY25 / financial reportMedia Release
FY25 / media releaseResults Announcement
FY25 / results announcementResults Presentation
FY25 / results presentationAnnual Report FY24
FY24 / financial reportMedia Release
FY24 / media releaseResults Announcement
FY24 / results announcementResults Presentation
FY24 / results presentationHalf Year Report - 1H25
HY25 / financial reportMedia Release - 1H25 Results
HY25 / media releaseResults Announcement - 1H25
HY25 / results announcementResults Presentation - 1H25
HY25 / results presentationOutcome of Summerset Annual Meeting
HY25 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 8.6pp, with a distortion flag in the result.
Dividend coverage and payout pressure
Company-disclosed payout ratio is 25.3% on a company-disclosed basis, with NPAT payout at n/a.
Revenue growth context
Revenue growth was 13.1% for this reporting period.
ROE and capital efficiency
ROE was 7.8%, -3.6pp versus the prior comparable period.
Get the next Summerset Group Holdings briefing and related NZX reporting-season updates by email.